How AST Results Supp...
16th December 2024 Content supplied by: Thermo Fisher Scientific (Clinical Applications)
Superbug Surcharge: The Economics of MDROs and HAIs
Superbug surcharge: The economics of MDROs and HAIs
Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) threaten patient health and impose significant financial burdens on healthcare systems, necessitating extended hospital stays and costly treatments.
Advancements in screening, detection, and treatment options can help healthcare facilities control the costs and impact of MDROs and HAIs, leading to better patient outcomes.
Download the Superbug surcharge: The economics of MDROs and HAIs infographic to discover:
- The global cost of treating MDRO carbapenem-resistant Acinetobacter baumannii plus recurrent Clostridioides difficile (C. diff) infections
- The global predicted cost in 2025 of Antimicrobial resistance (AMR), including MDROs
- How the variety of tools from Thermo Fisher Scientific can help combat MDROs/HAIs, tools such as:
- Thermo Scientific™ Brilliance™ and Spectra™ Chromogenic Media,
- Thermo Scientific™ Sensititre™ AST System,
- Thermo Scientific™ Oxoid™ AST Discs,
- Thermo Scientific™ Culti-Loops™ Quality Control Organisms
Tags:
Date Published: 16th December 2024
Source article link: View
How AST Results Support Accurate
Thermo Fisher Scientific (Clinical Applications)
Address:
Basingstoke
United Kingdom
Tel: +44 (0)7825093757
Related news from Thermo Fisher Scientific (Clinical Applications)
- How AST Results Support Accurate Antibiotic Therapy in the Battle Against Bacterial Sepsis
- New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing
- Research Panel Detects Four of the Most Common STI Pathogens With One Panel
- FDA EUA for TaqPath Monkeypox/Orthopox Virus DNA Kit
- Fast Forward to Actionable Results With Rapid AST
- New Non-Hazardous Viral Inactivation Medium Supports Safe Collection and Transport of SARS-CoV-2
- MIC Results in 6 Hours with New Rapid AST System
- Seasonal Flu and Coronavirus Identification
- Flu Testing During COVID-19
- Thermo Fisher's US Contract Will See 8 Million COVID-19 VTM-Filled Tubes Per Week
- Thermo Fisher's Taqman COVID-19 Diagnostic Kit Receives FDA Emergency Use Authorization
- Thermo Fisher Acquire Qiagen
- Thermo Fisher Join With Cedars-Sinai to Develop Advanced Analytical Workflows for Clinical Labs
- Thermo Fisher Focus on Microbiology at AACC
- New Microbroth Dilution Plates Provide Gold Standard-level MIC Accuracy for MDROs
- New Sensititre™ARIS HiQ™ AST System Automates Gold Standard MIC by Broth Microdilution
- World's First Smart qPCR Instruments
- Delafloxacin and Meropenem/Vaborbactam Now Available on Sensititre ID/AST System
- FDA-cleared Microbroth Dilution Plates for Delafloxacin and Meropenem/Vaborbactam
- New Bovine/Porcine-specific Standard Sensititre Plate